Protective effect of a cysteine prodrug and antioxidant, L-2-oxothiazolidine-4-carboxylate, against ethanol-induced gastric lesions in rats

Experimental and Toxicologic Pathology

Volumn 64, Issue 3, 2012, Pages 233-237

  Al Moutaery, Meshal ^a   Al Rayes, Hannan ^b   Al Swailam, Ramaiz ^b   Elfaki, Ibrahim ^b   Khan, Haseeb Ahmad ^c   Arshaduddin, Mohammad ^b   Tariq, Mohammad ^b  

^a PRINCE SULTAN CARDIAC CENTER   (Saudi Arabia)

^b The General Directorate of Armed Forces Health Services   (Saudi Arabia)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Anitoxidant; Cysteine precursor; Gastric secretion; Gastric ulcer; Glutathione; Myeloperoxidase; Sulfhydryls

Indexed keywords

2 OXO 4 THIAZOLIDINECARBOXYLIC ACID; ANTIOXIDANT; MYELOPEROXIDASE; PRODRUG; THIOL DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIULCER ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; FEMALE; LEUKOCYTE MIGRATION INHIBITION; MALE; NONHUMAN; RAT; STOMACH ACID SECRETION; STOMACH LESION; STOMACH MUCUS; STOMACH PROTECTION; STOMACH ULCER;

ANIMALS; ANTI-ULCER AGENTS; ANTIOXIDANTS; CYSTEINE; DISEASE MODELS, ANIMAL; ETHANOL; FEMALE; GASTRIC MUCOSA; MALE; PRODRUGS; PYRROLIDONECARBOXYLIC ACID; RATS; RATS, WISTAR; STOMACH ULCER; THIAZOLIDINES;

ANIMALIA; RATTUS;

EID: 84857033752     PISSN: 09402993     EISSN: 16181433     Source Type: Journal    
DOI: 10.1016/j.etp.2010.08.012     Document Type: Article

References (60)

1. Ali B.H., Al Moundhri M.S., Tag Eldin M., Nemmar A., Tanira M.O. The ameliorative effect of cysteine prodrug L-2-oxothiazolidine-4-carboxylic acid on cisplatin-induced nephrotoxicity in rats. Fundam Clin Pharmacol 2007, 21:547-553.
2. Allen A., Hutton D.A., Leonard A.J., Pearson J.P., Sellers L.A. The role of mucus in the protection of the gastroduodenal mucosa. Scand J Gastroenterol 1986, 21:71-77.
3. Allen A., Sellers L.A., Bennett M.K. The gastric mucosal epithelia barrier: role of mucus and fibrin. Scand J Gastroenterol 1987, 22:6-13.
4. Bell A.E., Sellers L.A., Allen A., Cunliffe W.J., Morris E.R., Ross Murphy S.B. Properties of gastric and duodenal musus: effect of proteolysis disulfide reduction, bile, acid, ethanol and hypertonicity on mucus gel structure. Gastroenterology 1985, 88:269-280.
5. Bernard G.R., Wheeler A.P., Arons M.M., Morris P.E., Paz H.L., Russell J.A., et al. A trial of antioxidants N-acetylcysteine and procysteine in ARDS. The Antioxidant in ARDS Study Group. Chest 1997, 112:164-172.
6. Bilbao P., del Olmo M., Alonso-Varona A., Castro B., Bilbao J., Palomares T. L-2-Oxothiazolidine-4-carboxylate reverses the tumour growth-promoting effect of interleukin-2 and improves the anti-tumour efficacy of biochemotherapy in mice bearing B16 melanoma liver metastases. Melanoma Res 2002, 12:17-26.
7. Boyd S.C., Sasame H.A., Boyd M.R. Gastric glutathione depletion and acute ulcerogenesis by diethylmaleate given subcutaneously to rats. Life Sci 1981, 28:2987-2992.
8. Bradley P.P., Priebat D.A., Christensen R.D., Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982, 78:206-209.
9. Breborowicz A., Witowski J., Polubinska A., Pyda M., Oreopoulos D. L-2-Oxothiazolidine-4-carboxylic acid reduces in vitro cytotoxicity of glucose degradation products. Nephrol Dial Transplant 2004, 19:3005-3011.
10. Corne S.J., Morrisey S.M., Woods R.J. A method for the quantitative estimation of gastric barrier mucus. J Physiol 1974, 242:116-117.
11. del Olmo M., Alonso-Varona A., Castro B., Bilbao P., Palomares T. Cytomodulation of interleukin-2 effect by L-2-oxothiazolidine-4-carboxylate on human malignant melanoma. Cancer Immunol Immunother 2006, 55:948-957.
12. Dizdar N., Kullman A., Kågedal B. Comparison of N-acetylcysteine and L-2-oxothiazolidine-4-carboxylate as cysteine deliverers and glutathione precursors in human malignant melanoma transplants in mice. Cancer Chemother Pharmacol 2000, 45(3):192-198.
13. Dursun H., Bilici M., Albayrak F., Ozturk C., Saglam M.B., Alp H.H., et al. Antiulcer activity of fluvoxamine in rats and its effect on oxidant and antioxidant parameters in stomach tissue. BMC Gastroenterol 2009, 9:36.
14. Elsbach P., Weiss J. Phagocytosis of bacteria and phospholipid degradation. Biochim Biophys Acta 1988, 947:29-52.
15. Erbil Y., Türkoglu U., Barbaros U., Balik E., Olgac V., Kaya H., et al. Oxidative damage in an experimentally induced gastric and gastroduodenal reflux model. Surg Innov 2005, 12:219-225.
16. Ferreira L.F., Gilliam L.A., Reid M.B. L-2-Oxothiazolidine-4-carboxylate reverses glutathione oxidation and delays fatigue of skeletal muscle in vitro. J Appl Physiol 2009, 107:211-216.
17. Goa K.L., Monk J.P. Enprotil: a preliminary review of its pharmacodynamics and pharmacokinetic properties and therapeutic efficacy in the treatment of peptic ulcer diseases. Drugs 1987, 3:539-559.
18. Gwilt P.R., Radick L.E., Li X.Y., Whalen J.J., Leaf C.D. Pharmacokinetics of 2-oxothiazolidine-4-carboxylate, a cysteine prodrug, and cysteine. J Clin Pharmacol 1998, 38:945-950.
19. Hayes J.D., McLellan L.I. Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. Free Radic Res 1999, 31:273-300.
20. Hernandez L.A., Grisham M.B., Twohigh B., Arfors K.E., Harlan J.M., Granger D.N. Role of neutrophils in ischemia reperfusion induced microvascular injury. Am J Physiol 1987, 253:699-703.
21. Hills B.A., Butler B.D., Lichtenberger L.M. Gastric mucosal barrier: hydrophobic lining to the lumen of the stomach. Am J Physiol 1983, 244:561-568.
22. Iimuro Y., Bradford B.U., Yamashina S., Rusyn I., Nakagami M., Enomoto N., et al. The glutathione precursor L-2-oxothiazolidine-4-carboxylic acid protects against liver injury due to chronic enteral ethanol exposure in the rat. Hepatology 2000, 31:391-398.
23. Kiviluoto T., Paimela H., Mustonen H., Kivilaakso E.L. Exogenous surface-active phospholipids protects necturus gastric mucosa against luminal acid and barrier-breaking agents. Gastroenterology 1991, 100:38-46.
24. Koc M., Imik H., Odabasoglu F. Gastroprotective and anti-oxidative properties of ascorbic acid on indomethacin-induced gastric injuries in rats. Biol Trace Elem Res 2008, 126:222-236.
25. Kvietys P.R., Twohigh B., Danzell J., Specian R.D. Ethanol-induced injury to the rat gastric mucosa. Gastroenterology 1990, 98:909-920.
26. Kwiecień S., Brzozowski T., Konturek S.J. Effects of reactive oxygen species action on gastric mucosa in various models of mucosal injury. J Physiol Pharmacol 2002, 53:39-50.
27. La Casa C., Villegas I., Alarcon de la Lastra C., Motilva V., Martin Calero M.J. Evidence for protective and antioxidant properties of rutin, a natural flavone, against ethanol-induced gastric lesions. J Ethnopharmacol 2000, 71:45-53.
28. Laine L., Weinstein W.M. Histology of alcoholic haemorrhagic gastritis: a prospective evaluation. Gastroenterology 1988, 94:1254-1264.
29. Lee Y.C., Lee K.S., Park S.J., Park H.S., Lim J.S., Park K.H., et al. Blockade of airway hyperresponsiveness and inflammation in a murine model of asthma by a prodrug of cysteine, L-2-oxothiazolidine-4-carboxylic acid. FASEB J 2004, 18:1917-1919.
30. Lee S., Moon S.O., Kim W., Sung M.J., Kim D.H., Kang K.P., et al. Protective role of L-2-oxothiazolidine-4-carboxylic acid in cisplatin-induced renal injury. Nephrol Dial Transplant 2006, 21:2085-2095.
31. Levy M.A., Sikorski B., Bray T.M. Selective elevation of glutathione levels in target tissues with L-2-oxothiazolidine-4-carboxylate (OTC) protects against hyperoxia-induced lung damage in protein-energy malnourished rats: implications for a new treatment strategy. J Nutr 1998, 128:671-676.
32. Loguercio C., Blanco F.D., De Girolamo V., Disalvo D., Nardi G., Parente A., et al. Ethanol consumption, amino acid and glutathione blood levels in patients with and without chronic liver disease. Alcohol Clin Exp Res 1999, 23:1780-1784.
33. Martin G.R., Wallace J.L. Gastrointestinal inflammation: a central component of mucosal defense and repair. Exp Biol Med 2006, 231:130-137.
34. Meister A. Selective modification of glutathione metabolism. Science 1983, 220:472-477.
35. Moberly J.B., Logan J., Borum P.R., Story K.O., Webb L.E., Jassal S.V., et al. Elevation of whole-blood glutathione in peritoneal dialysis patients by L-2-oxothiazolidine-4-carboxylate, a cysteine prodrug (Procysteine). J Am Soc Nephrol 1998, 9:1093-1099.
36. 2 and ethanol. Am J Physiol 1985, 249:137-144.
37. Natale G., Lazzeri G., Blandizzi C., Gherardi G., Lenzi P., Pellegrini A., et al. Seriate histomorphometry of whole rat stomach: an accurate and reliable method for quantitative analysis of mucosal damage. Toxicol Appl Pharmacol 2001, 174:17-26.
38. Nemmar A., Al-Salam S., Dhanasekaran S., Sudhadevi M., Ali B.H. Pulmonary exposure to diesel exhaust particles promotes cerebral microvessel thrombosis: protective effect of a cysteine prodrug L-2-oxothiazolidine-4-carboxylic acid. Toxicology 2009, 263:84-92.
39. Otis J.S., Guidot D.M. Procysteine stimulates expression of key anabolic factors and reduces plantaris atrophy in alcohol-fed rats. Alcohol Clin Exp Res 2009, 33:1450-1459.
40. Patel H.M., Santani D.D., Goswami S.G. Evaluation of the effects of nicorandil on experimentally induced gastric ulcers. Pharmacology 2001, 63:154-159.
41. Pihan G., Regillo C., Szabo S. Free radicals and lipid peroxidation in ethanol- or aspirin-induced gastric mucosal injury. Dig Dis Sci 1987, 32:1395-1401.
42. Poon B.Y., Goddard C.M., Leaf C.D., Russell J.A., Walley K.R. L-2-Oxothiazolidine-4-carboxylic acid prevents endotoxin-induced cardiac dysfunction. Am J Respir Crit Care Med 1998, 158:1109-1113.
43. Saberi M., Zaree Mahmodabady A. The protective effects of N-Acetl-cysteine, oxo-thiazolidine-carboxylate, acetaminophen and their combinations against sulfur mustard cytotoxicity on human skin fibroblast cell line (HF2FF). Iran Biomed J 2009, 13:215-221.
44. Schiantarelli P., Cadel S., Folco G.C. Gastroprotective effects of morniflumate, an esterified anti-inflammatory drug. Arzneim Forsch 1984, 34:885-890.
45. Sedlak J., Lindsay R.H. Estimation of total protein bound and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem 1968, 25:192-195.
46. Sehirli O., Tatlidede E., Yüksel M., Erzik C., Cetinel S., Yeĝen B.C., et al. Antioxidant effect of alpha-lipoic acid against ethanol-induced gastric mucosal erosion in rats. Pharmacology 2008, 81:173-180.
47. Shay H., Komarov S.A., Fels S.E., Merze D., Gruenstein M., Siplet H. A simple method for the uniform production of gastric ulceration in the rat. Gastroenterology 1945, 5:43-61.
48. Shimizu N., Watanabe T., Arakawa T., Fujiwara Y., Higuchi K., Kuroki T. Pentoxyfyllin accelerates gastric ulcer healing in rats: roles of tumor necrosis factor α and neutrophils during the early phase of ulcer healing. Digestion 2000, 61:157-164.
49. Slomiany B.L., Piasek A., Sarosiek J., Slomiany A. The role of surface and intracellular mucus in gastric mucosal protection against hydrogen ion. Compositional differences. Scand J Gastroenterol 1985, 20:1191-1196.
50. Suzuki Y., Ishihara M., Segami T., Ito M. Anti-ulcer effects of antioxidants, quercetin, alpha-tocopherol, nifedipine and tetracycline in rats. Jpn J Pharmacol 1998, 78:435-441.
51. Szabo S., Trier J.S., Frankel P.W. Sulfhydryl compounds may mediate gastric cytoprotection. Science 1981, 214:200-202.
52. Takeuchi Y., Kitano S., Bandoh T., Matsumoto T., Baatar D., Kai S. Accelaration of gastric ulcer healing by omeprazole in portal hypertensive rats. Is its action mediated by gastrin release and the stimulation of epithelial proliferation?. Eur Surg Res 2003, 35:75-80.
53. Tariq M., Al Moutaery M., Elfaki I., Arshaduddin M., Khan H.A. Protective effects of nedocromil sodium and sodium cromoglycate on gastroduodenal ulcers: a comparative study in rats. Inflammopharmacology 2006, 14:163-169.
54. Tariq M., Elfaki I., Khan H.A., Arshaduddin M., Sobki S., Al Moutaery M. Bromophenacyl bromide, a phospholipase A2 inhibitor attenuates chemically induced gastroduodenal ulcers in rats. World J Gastroenterol 2006, 13:5798-5804.
55. Tariq M., Khan H.A., Elfaki I., Arshaduddin M., Al Moutaery M., Rayes H., et al. Gastric antisecretory and antiulcer effects of simvastatin in rats. J Gastroenterol Hepatol 2006, 22:2316-2323.
56. Vita J.A., Frei B., Holbrook M., Gokce N., Leaf C., Keaney J.F. L-2-Oxothiazolidine-4-carboxylic acid reverses endothelial dysfunction in patients with coronary artery disease. J Clin Invest 1998, 101:1408-1414.
57. Wallace J.L. Cooperative modulation of gastrointestinal mucosal defence by prostaglandins and nitric oxide. Clin Invest Med 1996, 19:346-351.
58. Wallace J.L., Whittle B.J.R. Role of mucus in the repair of gastric epithelial damage in the rat. Gastroenterology 1986, 91:603-611.
59. Wu G., Fang Y.Z., Yang S., Lupton J.R., Turner N.D. Glutathione metabolism and its implications for health. J Nutr 2004, 134:489-492.
60. Zhu A., Kaunitz J. Gastroduodenal mucosal defense. Curr Gastroenterol Rep 2008, 10:548-554.